Aller au contenu

← Journal/13 July 2026·3 min de lecture

CBD and the menopause: what we really know in 2026

Par ·

To date, no clinical study has specifically demonstrated an effect of CBD on hot flushes, according to the scientific reviews published between 2024 and 2025. Preliminary data point to modulation via TRPV1 receptors, without clinical confirmation at this stage. In France, moreover, no health claim is authorised for CBD products, as MILDECA and the DGCCRF point out.

CBD and the menopause: what we really know in 2026

What scientific research does, and does not, say

The menopause comes with a variety of symptoms — hot flushes, disturbed sleep, irritability — which lead some women to take an interest in CBD as a wellbeing product. But no clinical study has, to date, specifically demonstrated an effect of CBD on hot flushes, according to the reviews published in 2024 and 2025.

This absence of evidence does not necessarily mean an absence of effect, but it does mean that no reliable conclusion can be drawn in the current state of knowledge. The distinction matters: a lack of data does not amount to a validation, even partial, of a particular use.

The TRPV1 receptor lead: promising but unconfirmed

Preliminary data point to possible modulation, by CBD, of TRPV1 receptors, which are involved in particular in the regulation of body temperature, according to the preliminary literature available. This mechanism remains a research hypothesis, not an established clinical result in humans in the context of the menopause.

TRPV1 receptors are involved in several physiological processes beyond thermoregulation, which complicates the interpretation of this early data. Dedicated clinical trials would be needed to establish a solid causal link between CBD and hot flushes, and none exists today.

Why no health claim is authorised in France

In France, no health claim is authorised for CBD products, whatever the symptom targeted, as MILDECA and the DGCCRF point out. A seller therefore cannot lawfully present a CBD product as a means of treating, relieving or preventing the symptoms of the menopause.

This rule protects consumers from marketing that would run ahead of the science. It also explains why serious information on the subject remains cautious and conditional, pending dedicated and robust clinical studies in this specific population.

What women interested in CBD can do

A menopausal woman who wishes to try CBD as part of a general wellbeing approach may do so, bearing in mind that no specific effect on menopause symptoms is scientifically proven today. CBD in no way replaces medical advice or a prescribed hormone treatment.

It remains preferable to discuss it with a healthcare professional, particularly if you are on any current treatment, before including CBD in a routine. Our article on CBD among seniors in France covers more broadly the precautions to know for this age group.

Frequently asked questions

Does CBD reduce menopausal hot flushes?

No clinical study has, to date, specifically demonstrated this effect, according to the 2024-2025 reviews. Hypotheses exist regarding TRPV1 receptors, but nothing is clinically confirmed in humans.

Can CBD lawfully be sold "against" the menopause in France?

No. No health claim is authorised for CBD products in France, as MILDECA and the DGCCRF point out, whatever the symptom targeted by the commercial message.

What is the TRPV1 mechanism mentioned in connection with CBD?

It is a receptor involved in the regulation of body temperature. Preliminary data suggest possible modulation by CBD, without clinical confirmation in the specific context of the menopause.

Can CBD replace a hormone treatment for the menopause?

No. CBD is not a medicine and does not replace any prescribed treatment. Any question about managing menopause symptoms should be put to a healthcare professional.


Written by the Phytogrammes team

Every article in this journal draws on primary sources (ANSM, EFSA, EUR-Lex, peer-reviewed publications) and on the lab's own practice: batch-by-batch HPLC analyses, measured cannabinoid profiles. Our approach.

Article published on . CBD is not a medicine.

Phytogrammes products that pair well